Riber 2011 first-quarter revenues

RIBER, the global leader for molecular beam epitaxy (MBE), recorded €5.7 million in revenues for the first quarter of 2011, up 98% in relation to the first quarter of 2010, with its order book climbing 134% compared with last year to €21.3 million.

Growth in business is being driven by the development of systems sales, with two machines delivered during the first quarter. This is combined with the increase in sales of evaporation sources and cells, multiplied by nine compared with the same period in 2010. This change reflects ongoing move to diversify RIBER’s activities on the strongly growing OLED (Organic LED) and thin-layer solar panel (CIGS technology) markets.

Sales of services and accessories are down temporarily compared with the high level seen in the first quarter of 2010. The positive evolution of revenues also results from Riber’s policy aiming to evenly spread production throughout the year. Strong outlook for 2011 The order book at the end of March 2011 came to €21.3 million, 134% higher than the same period in 2010. It consists of six research systems and four production systems, with the company receiving an order for a new production machine in March. Out of these 10 machines in the order book, only one system is not scheduled to be delivered during the year. In addition, the book includes major effusion cell orders in the OLED sector.

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Previous Post

Mirror plants enable AWS Electronics to deliver top quality, best price cable assembly service

Next Post

New “Light Line” pedestrian warning system utilizes LEDs from OSRAM Opto Semiconductors to increase safety when crossing the street